Initial serum potassium levels of 5.5 mmol/L or higher in emergency department patients associate with a sharply elevated risk of cardiac arrest, ventricular arrhythmias, and death within 48 hours, according to a retrospective analysis published September 16, 2026, in The American Journal of Emergency Medicine. Researchers utilizing the TriNetX Research Network found that short-term composite risks escalate alongside potassium concentrations, rising from roughly 3% for mildly elevated levels to over 6% for severe hyperkalemia, Medscape reported.
Emergency Department Potassium Thresholds And 48-Hour Cardiac Risks
The retrospective cohort study evaluated adult patients visiting United States emergency departments between 2010 and 2024. Out of 141,938 individuals presenting with potassium levels at or above 5.5 mmol/L, investigators included 140,288 patients after propensity score matching. The study categorized initial serum potassium measurements into specific tiers to track short-term adverse clinical outcomes within a 48-hour window.
For patients with potassium levels ranging from 5.5 to 5.99 mmol/L, a composite primary outcome of cardiac arrest, ventricular tachycardia (VT), or ventricular fibrillation (VF) occurred in 3.05% of cases. That rate climbed progressively to 6.68% for patients presenting with potassium levels of 7.0 mmol/L or higher. By comparison, matched normokalemic control individuals experienced these cardiac events at rates between 0.77% and 0.90%. This translates to relative risks ranging from 3.97 to 8.08 and absolute increases of 2.28 to 5.85 percentage points.
Secondary Complications And Intensive Care Unit Admissions
Beyond life-threatening arrhythmias, severe electrolyte imbalances triggered high rates of intensive care unit admissions and mechanical ventilation within the 48-hour observation period. Intensive care unit admissions were recorded in 8.46% of patients with potassium levels between 5.5 and 5.99 mmol/L. That figure peaked at 13.28% for patients in the 6.5 to 6.99 mmol/L stratum, compared with approximately 4% in matched control populations.
The analysis also identified a significant correlation between elevated potassium and acute metabolic disturbances. Hypoglycemia within 24 hours of measurement occurred with markedly higher frequency across all hyperkalemic tiers, showing relative risks between 3.32 and 6.55 compared with control groups.
Borderline Potassium Elevations In Acute Care Settings
An exploratory arm of the research evaluated borderline potassium elevation, defined as levels between 5.01 and 5.49 mmol/L. Examining 1,249,213 patients matched to normokalemic controls, investigators observed the primary composite cardiac outcome in 1.52% of the borderline group versus 0.85% of control individuals. However, isolated rates of ventricular tachycardia and ventricular fibrillation did not demonstrate a statistically significant increase within this borderline tier.
Lead investigator Joseph O’Brien of Denver Health Medical Center in Denver, Colorado, and colleagues noted that the findings position potassium as an accessible risk marker in acute care environments. The authors cautioned that the retrospective design does not establish direct causality or prove that aggressive intervention alters short-term trajectories. Future prospective investigations incorporating electrocardiographic data, vital signs, serial measurements, and precise treatment timing remain necessary to isolate the independent contribution of hyperkalemia to early emergency department outcomes.
Study Methodology Limitations And Confounding Factors
The analysis carries several inherent limitations typical of retrospective database research. Investigators noted potential residual confounding driven by acute illness severity, as the dataset lacked information regarding presenting complaints, mental status, lactate levels, sepsis severity, validated clinical scores, and electrocardiogram abnormalities. Furthermore, residual imbalances in baseline creatinine and bicarbonate persisted following matching, particularly within the 6.0 to 6.49 mmol/L stratum. The 48-hour window also captured events that may have followed substantial shifts in potassium levels or interventions directed at lowering potassium, while exact treatment timing and serial lab values were unavailable.
Frequently Asked Questions About Emergency Potassium Levels
What specific potassium range constitutes severe hyperkalemia in this study?
Researchers classified severe hyperkalemia at the highest tier, where initial serum potassium reached or exceeded 7.0 mmol/L. At this threshold, the 48-hour composite risk for cardiac arrest, ventricular tachycardia, or ventricular fibrillation reached 6.68%.
Were the researchers able to determine if treating hyperkalemia immediately reduced mortality?
No, the study design did not establish causality or evaluate whether more aggressive treatment protocols successfully lowered adverse clinical outcomes. The authors emphasized that additional prospective studies are required to determine if targeted interventions modify early patient trajectories.
Did borderline high potassium levels trigger ventricular arrhythmias?
Patients with borderline potassium levels between 5.01 and 5.49 mmol/L experienced an elevated composite cardiac risk of 1.52% compared with 0.85% in controls, but the rates of isolated ventricular tachycardia and ventricular fibrillation did not increase significantly.
Who led the TriNetX database analysis?
The research was led by Joseph O’Brien of Denver Health Medical Center in Denver, Colorado, and published online on September 16, 2026.